James Rolke, Chief Scientific Officer at LA JOLLA PHARMACEUTICAL CO (LJPC), bought 1,600 shares at $6.10 ($10K) on 2019-01-09, disclosed to the SEC on 2019-01-09.
Open-market purchase of $10k LJPC by Chief Scientific Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.07 | 300 | $2K | 18.7% |
| 2 | $6.09 | 500 | $3K | 31.2% |
| 3 | $6.10 | 800 | $5K | 50.1% |
| Total | $6.09 avg | 1,600 | $10K | 100% |